Citation: Ag. Hobson et Km. Sowinski, TICLOPIDINE AND ASPIRIN THERAPY FOLLOWING IMPLANTATION OF CORONARY-ARTERY STENTS, The Annals of pharmacotherapy, 31(6), 1997, pp. 770-772
Authors:
CLARK WR
LEYPOLDT JK
HENDERSON LW
SOWINSKI KM
SCOTT MK
MUELLER BA
VONESH EF
Citation: Wr. Clark et al., EFFECT OF CHANGES IN DIALYTIC FREQUENCY, DURATION AND FLOW-RATES ON SOLUTE KINETICS AND EFFECTIVE CLEARANCES, Journal of the American Society of Nephrology, 8, 1997, pp. 1285-1285
Citation: Km. Sowinski et Bs. Burlew, IMPACT OF CYP2D6 POOR METABOLIZER PHENOTYPE ON PROPRANOLOL PHARMACOKINETICS AND RESPONSE, Pharmacotherapy, 17(6), 1997, pp. 1305-1310
Authors:
SOWINSKI KM
LIMA JJ
BURLEW BS
MASSIE JD
JOHNSON JA
Citation: Km. Sowinski et al., RACIAL-DIFFERENCES IN PROPRANOLOL ENANTIOMER KINETICS FOLLOWING SIMULTANEOUS IV AND ORAL-ADMINISTRATION, British journal of clinical pharmacology, 42(3), 1996, pp. 339-346
Authors:
SOWINSKI KM
FORREST A
WILTON JH
TAYLOR AM
WILSON MF
KAZIERAD DJ
Citation: Km. Sowinski et al., EFFECT OF AGING ON ATENOLOL PHARMACOKINETICS AND PHARMACODYNAMICS, Journal of clinical pharmacology, 35(8), 1995, pp. 807-814
Citation: Km. Sowinski et al., RACIAL-DIFFERENCES IN SENSITIVITY TO THE NEGATIVE CHRONOTROPIC EFFECTS OF PROPRANOLOL IN HEALTHY-MEN, Clinical pharmacology and therapeutics, 57(6), 1995, pp. 678-683
Authors:
SOWINSKI KM
BURLEW BS
MASSIE JD
JOHNSON JA
Citation: Km. Sowinski et al., RACIAL-DIFFERENCES IN INTRAVENOUS (IV) PROPRANOLOL KINETICS AT STEADY-STATE, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 165-165